利润表
RELMADA THERAPEUTICS, INC.
RLMD
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Jun 30, 2019 2019 FY | Jun 30, 2018 2018 FY | Jun 30, 2017 2017 FY | Jun 30, 2016 2016 FY | Jun 30, 2015 2015 FY | Aug 31, 2013 2013 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
- | - | - | - | - | - | - | - | - | - | - | 0.01 |
|
营业成本
|
- | - | - | - | - | - | - | - | - | - | - | 0.00 |
|
毛利润
|
- | - | - | - | - | - | - | - | - | - | - | 0.00 |
|
营业费用
|
59.10 | 83.89 | 103.70 | 161.25 | 125.70 | 60.84 | 12.73 | 6.92 | 7.22 | 16.22 | 17.10 | 0.05 |
|
研发费用
|
26.88 | 46.18 | 54.81 | 113.32 | 90.62 | 35.97 | 7.02 | 2.94 | 1.29 | 6.21 | 7.87 | - |
|
销售、一般及行政费用
|
32.22 | 37.72 | 48.89 | 47.93 | 35.08 | 24.87 | 5.70 | 3.97 | 5.93 | 10.01 | 9.23 | 0.05 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-59.10 | -83.89 | -103.70 | -161.25 | -125.70 | -60.84 | -12.73 | -6.92 | -7.22 | -16.22 | -17.10 | -0.05 |
|
营业外收入
|
1.72 | 3.91 | 4.91 | 4.21 | -0.05 | 1.38 | -4.59 | -2.04 | - | - | - | - |
|
利息收入
|
1.40 | 3.53 | - | - | - | - | - | - | - | - | 0.01 | - |
|
利息支出
|
- | - | - | - | - | - | - | - | - | - | 0.00 | - |
|
其他营业外收入/支出
|
- | - | - | - | - | - | - | - | 0.93 | 13.24 | -3.70 | - |
|
税前利润
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
所得税费用
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
-57.39 | -79.98 | -98.79 | -157.04 | -125.75 | -59.46 | -17.32 | -8.96 | 6.29 | 2.97 | 24.51 | -0.05 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Jun 30, 2019 2019 FY | Jun 30, 2018 2018 FY | Jun 30, 2017 2017 FY | Jun 30, 2016 2016 FY | Jun 30, 2015 2015 FY | Aug 31, 2013 2013 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-59.10 | -83.89 | -103.70 | -161.25 | -125.70 | -60.84 | -12.73 | -6.92 | -7.22 | -16.22 | -17.10 | -0.05 |
|
基本每股收益
|
-1.45 | -2.65 | -3.28 | -5.30 | - | - | - | - | - | - | - | - |
|
稀释每股收益
|
-1.45 | -2.65 | - | - | - | - | - | - | - | - | - | - |
|
加权平均股数
|
39.48 | 30.16 | 30.10 | 29.63 | - | - | - | - | - | - | - | - |
|
稀释加权平均股数
|
39.48 | 30.16 | - | - | - | - | - | - | - | - | - | - |
|
综合收益
|
- | - | - | - | - | - | - | - | - | - | - | - |